STOCK TITAN

3D Systems Corporation (DDD) Stock News, Sep-Nov 2022

DDD NYSE

3D Systems Corporation develops additive manufacturing and digital manufacturing solutions built around 3D printers, materials, software and application engineering services. Its news commonly covers production systems for polymers and metals, NextDent dental printing and materials, SLA technology, factory software such as AddiTrak, and customer deployments in medical, dental, aerospace, defense, transportation, motorsports and industrial markets.

Company updates also include financial results, cost and efficiency programs, leadership changes, regulatory certifications for dental products, and commercial adoption of healthcare and industrial applications. These developments reflect the company’s focus on full-service solutions that combine hardware, materials, software and manufacturing expertise.

Rhea-AI Summary

3D Systems (NYSE: DDD) has introduced two new materials, Certified HX and Certified CuCr2.4, enhancing its materials portfolio for 3D printing. Certified HX is a high-performance nickel alloy, ideal for high-temperature applications up to 1200°C, while Certified CuCr2.4 offers improved strength and conductivity for cooling systems. Both materials are optimized for use with DMP Flex 350 and DMP Factory 350 printers. These innovations aim to meet the increasing demands in industries like energy, aerospace, and automotive, showcasing 3D Systems' commitment to advancing additive manufacturing technology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.10%
Tags
none
-
Rhea-AI Summary

3D Systems (NYSE: DDD) has partnered with ALM to include DuraForm® PAx in ALM's materials portfolio. This innovative nylon copolymer is aimed at industrial applications, offering lower costs and high recyclability. DuraForm PAx is engineered for high impact and elongation performance, making it suitable for diverse applications such as orthotics and tooling. The collaboration enhances material options for customers using Selective Laser Sintering (SLS) technologies and signifies a commitment to innovation in additive manufacturing. Both companies will showcase this material at Formnext 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.22%
Tags
partnership
-
Rhea-AI Summary

3D Systems Corporation (NYSE: DDD) reported a 15.3% decrease in revenue to $132.3 million for Q3 2022, impacted by divestitures and a decline in dental market sales. Despite challenges, non-GAAP revenue, excluding divestitures, grew 2.7%. The company experienced a net loss of $(37.4) million and a diluted loss per share of $(0.30). Adjusted EBITDA stood at $(0.3) million, reflecting inflationary pressures. Cash and short-term investments totaled $609.4 million. FY 2022 revenue guidance was revised to $535 - $545 million, with improved outlook on operating expenses.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.69%
Tags
Rhea-AI Summary

3D Systems (NYSE: DDD) will release its third quarter 2022 financial results after U.S. markets close on November 8, 2022. A conference call and webcast to discuss the results will be held on November 9, 2022, at 8:30 a.m. ET. The company has been a leader in additive manufacturing solutions for over 35 years, serving various industries including healthcare, aerospace, and automotive. Investors can access the webcast and replay through the company's investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.02%
Tags
-
Rhea-AI Summary

3D Systems (NYSE: DDD) announced that Amnovis, a Belgium-based additive manufacturing company, has integrated the DMP Flex 350 Dual into its production workflow. This dual-laser solution enhances productivity by at least 50% compared to single-laser systems while reducing costs. Amnovis aims to leverage this technology for high-quality medical devices and industrial applications. The DMP Flex 350 Dual offers flexible application use and efficient management of print jobs, contributing to a competitive edge in both medical and industrial sectors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.69%
Tags
none
-
Rhea-AI Summary

3D Systems (NYSE:DDD) will participate in William Blair’s virtual panel, “Advancing Healthcare Through 3D Bioprinting,” on September 23, 2022, at 12:00 p.m. ET. This event highlights advancements in healthcare via 3D printing technology. A recording will be accessible on their website post-event for seven days. With over 35 years of experience, 3D Systems leads in additive manufacturing, offering tailored solutions in diverse sectors like healthcare, aerospace, and automotive.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.63%
Tags
conferences
Rhea-AI Summary

3D Systems (NYSE:DDD) has announced that Andrew Johnson, executive vice president and chief legal officer, will also serve as chief corporate development officer. This dual role includes overseeing mergers and acquisitions and forging new strategic partnerships. Johnson's extensive experience, including the completion of over 60 M&A transactions, positions him well for these expanded responsibilities. The company aims to capitalize on emerging opportunities in regenerative medicine through strategic partnerships, leveraging its recent acquisitions and technological advancements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.57%
Tags
management
-
Rhea-AI Summary

3D Systems announced two new production-grade materials: Figure 4 Tough Clear and DuraForm PAx Black. Figure 4 Tough Clear is the company's first clear material designed for long-term use, featuring enhanced clarity and mechanical properties for applications like lenses and consumer goods. DuraForm PAx Black offers injection-molding-like properties with low-temperature printing, high impact resistance, and significant long-term stability. Both materials aim to facilitate rapid production and integration into existing workflows, targeting various industrial applications. Availability is set for Q4 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.19%
Tags
none
-
Rhea-AI Summary

3D Systems (NYSE:DDD) has announced the launch of a new biotech company, Systemic Bio, aimed at revolutionizing drug development by leveraging advanced bioprinting technologies. The company will utilize its proprietary h-VIOS™ organ-on-a-chip platform to create vascularized human tissues for drug testing, potentially reducing costs and the reliance on animal testing. Initial seed funding of $15 million is provided, with expected revenues nearing $100 million annually within five years. Taci Pereira is appointed as CEO, bringing extensive experience in bioengineering.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.06%
Tags
none
Rhea-AI Summary

3D Systems has partnered with HII to develop the copper-nickel alloy CuNi30, designed for direct metal printing. This innovation can potentially reduce lead times by up to 75%, addressing the needs in marine, offshore oil & gas, and chemical industries. The alloy boasts an average relative density of 99.88%, significantly surpassing traditional casting methods. CuNi30 will be available in Q4 2022, enhancing supply chain efficiency while minimizing inventory costs. This advancement could revolutionize manufacturing processes in sectors requiring corrosion-resistant materials.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.02%
Tags
none

FAQ

What is the current stock price of 3D Systems (DDD)?

3D Systems (DDD) last closed at $2.78.

What is the market cap of 3D Systems (DDD)?

The market cap of 3D Systems (DDD) is approximately $461.9M.